Physicians' Academy for Cardiovascular Education

Addressing late-breaking data on triglycerides, fibrates and omega-3FAs

15' education - Nov. 16, 2022 - Prof. Peter Libby, MD (Boston, MA, USA), Prof. Gabriel Steg, MD (Paris, France) and Prof. Kausik Ray, MD (London, UK)

Video navigation menu

  • The PROMINENT trial 0:59
  • Outcomes of trials with omega-3FAs 3:53
  • Mechanism of action of EPA? 7:43
  • Translation of trial results to clinical practice 9:23
  • How do we overcome clinical inertia? 12:53


Show transcript

Educational information

This video was recorded during the American Heart Association’s Scientific Sessions 2022 in Chicago, IL, USA.



This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.


Funding for this educational material was provided by an unrestricted educational grant received from Amarin.

Read our summary of RESPECT-EPA Read our summary of PROMINENT

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.

Share this page with your colleagues and friends: